Report : Europe Hemodynamic Monitoring System Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Non-Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, and Invasive Hemodynamic Monitoring Systems), Product (Monitors and Disposables), and End User (Hospitals, Home Care, Cath Labs, and Ambulatory Care Center)
At 6.0% CAGR, the Europe Hemodynamic Monitoring System Market is speculated to be worth US$ 616.34 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Europe hemodynamic monitoring system market was valued at US$ 434.63 million in 2022 and is expected to reach US$ 616.34 million by 2028, registering a CAGR of 6.0% from 2022 to 2028. Rising cardiovascular disease prevalence and growing geriatric population are the critical factors attributed to the Europe hemodynamic monitoring system market expansion.
Cardiovascular diseases (CVDs) cause millions of deaths every year worldwide. CVDs majorly cause mortality and morbidity in Europe, accounting for 45% of deaths in the region and 37% in the European Union (EU). Hemodynamic monitors allow measurement of cardiac functions and blood circulation in cardiac patients. The monitoring allows physicians to measure blood pressure from inside the veins, arteries, and heart. Thus, growing prevalence of cardiovascular diseases is surging the demand for Europe hemodynamic monitoring system market during the forecast period.
On the contrary, risks associated with invasive hemodynamic monitoring systems hampers the Europe hemodynamic monitoring system market.
Based on type, Europe hemodynamic monitoring system market is segmented into non-invasive hemodynamic monitoring systems, minimally invasive hemodynamic monitoring systems, and invasive hemodynamic monitoring systems. The invasive hemodynamic monitoring systems segment held 77.2% share of Europe hemodynamic monitoring system market in 2022, amassing US$ 335.59 million. It is projected to garner US$ 469.10 million by 2028 to expand at 5.7% CAGR during 2022–2028.
Based on product, the Europe hemodynamic monitoring system market is segmented into monitors and disposables. The disposables held 69.7% share of Europe hemodynamic monitoring system market in 2022, amassing US$ 303.14 million. It is projected to garner US$ 422.19 million by 2028 to expand at 5.7% CAGR during 2022–2028.
Based on end user, the Europe hemodynamic monitoring system market is segmented into hospitals, home care, cath labs, and ambulatory care center. The hospitals segment held 88.7% share of Europe hemodynamic monitoring system market in 2022, amassing US$ 385.57 million. It is projected to garner US$ 552.81 million by 2028 to expand at 6.2% CAGR during 2022–2028.
Based on country, the Europe hemodynamic monitoring system market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 27.6% share of Europe hemodynamic monitoring system market in 2022. It was assessed at US$ 119.97 million in 2022 and is likely to hit US$ 178.06 million by 2028, exhibiting a CAGR of 6.8% during the forecast period.
Key players dominating the Europe hemodynamic monitoring system market are Baxter International Inc; Change Healthcare; DELTEX MEDICAL; Edwards Lifesciences Corporation; General Electric Co; Getinge Group; ICU MEDICAL INC.; International Business Machines Corp; Koninklijke Philips NV; Masimo; Osypka Medical GmbH; Schwarzer Cardiotek; and Siemens Healthineers AG, among others.
- In April 2019; Edwards Lifesciences Completed the Acquisition of CASMED. CAS Medical Systems, Inc., a medical technology company dedicated to non-invasive brain and tissue oxygenation monitoring. Edwards has acquired CASMED's FORE-SIGHT non-invasive cerebral oxygenation technology. Edwards plans to pair the FORE-SIGHT technology with the company's HemoSphere advanced hemodynamic monitoring platform, which would create a unique offering of enhanced recovery tools and predictive analytics capabilities for clinicians. The acquisition of the FORE-SIGHT technology represents an opportunity to grow the Edwards critical care portfolio and further strengthen the company's leadership in smart monitoring technologies.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com